MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to O...
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
About this item
Full title
Author / Creator
Tourbah, Ayman , Gout, Olivier , Vighetto, Alain , Deburghgraeve, Véronique , Pelletier, Jean , Papeix, Caroline , Lebrun-Frenay, Christine , Labauge, Pierre , Brassat, David , Toosy, Ahmed , Laplaud, David-Axel , Outteryck, Olivier , Moreau, Thibault , Debouverie, Marc , Clavelou, Pierre , Heinzlef, Olivier , De Sèze, Jérôme , Defer, Gilles , Sedel, Frédéric and Arndt, Carl
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Chronic visual loss is a disabling feature in patients with multiple sclerosis (MS). It was recently shown that MD1003 (high-dose pharmaceutical-grade biotin or hdPB) may improve disability in patients with progressive MS.
Objective
The aim of this study was to evaluate whether MD1003 improves vision compared with placebo in MS...
Alternative Titles
Full title
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
Authors, Artists and Contributors
Author / Creator
Gout, Olivier
Vighetto, Alain
Deburghgraeve, Véronique
Pelletier, Jean
Papeix, Caroline
Lebrun-Frenay, Christine
Labauge, Pierre
Brassat, David
Toosy, Ahmed
Laplaud, David-Axel
Outteryck, Olivier
Moreau, Thibault
Debouverie, Marc
Clavelou, Pierre
Heinzlef, Olivier
De Sèze, Jérôme
Defer, Gilles
Sedel, Frédéric
Arndt, Carl
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6061426
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6061426
Other Identifiers
ISSN
1172-7047
E-ISSN
1179-1934
DOI
10.1007/s40263-018-0528-2
